Skip to main content

Table 3 Median and quartile serum concentrations of PFAS in all subjects under covariate status

From: Perfluoroalkyl and polyfluoroalkyl substance exposure and association with sex hormone concentrations: results from the NHANES 2015–2016

Concentration (ng/mL) PFDeA PFHxS PFNA n-PFOA n-PFOS Sm-PFOS
Males       
 12–19 0.10 (0.07,0.20)** 1.00 (0.70,1.60)** 0.50 (0.40,0.70)** 1.30 (1.00,1.70)** 2.40 (1.70,3.50)** 1.00 (0.80,1.40)**
 20–49 0.01 (0.07,0.20) 1.60 (1.10,2.60) 0.60 (0.40,0.80) 1.80 (1.30,2.40) 3.70 (2.50,5.80) 1.90 (1.30,3.00)
 ≥ 50 0.20 (0.07,0.30) 1.80 (1.20,2.90) 0.80 (0.50,1.10) 2.10 (1.40,2.70) 5.60 (3.40,9.20) 2.90 (1.80,4.40)
Females       
 12–19 0.07 (0.07,0.20)** 0.70 (0.40,1.30)** 0.40 (0.30,0.60)** 1.00 (0.70,1.40)** 1.70 (1.20,2.30)** 0.70 (0.50,0.90)**
 20–49 0.10 (0.07,0.20) 0.60 (0.40,1.10) 0.40 (0.30,0.70) 1.00 (0.60,1.60) 2.00 (1.20,3.00) 0.80 (0.50,1.30)
 ≥ 50 0.20 (0.10,0.30) 1.30 (0.80,2.20) 0.70 (0.50,1.10) 1.80 (1.20,2.60) 4.00 (2.50,6.50) 1.90 (1.00,3.40)
  1. *P < 0.05; **P < 0.01